Follow NBC News Cold & Flu
FDA approves bird flu vaccine with adjuvant
The U.S. Food and Drug Administration said on Friday it has approved a vaccine made by GlaxoSmithKline Plc for use in the event of an H5N1 bird flu epidemic. The vaccine will be added to the national stockpile and will not be available for commercial use, the FDA said. The vaccine does not have a trade name in the United States.